Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post
The Jakarta Post
Video Weather icon 30°C
DKI Jakarta, Indonesia
weather-icon
30°C Partly Cloudy

Dry and mostly cloudy throughout the day.

  • weather-icon

    Wed

    26℃ - 32℃

  • weather-icon

    Thu

    25℃ - 32℃

  • weather-icon

    Fri

    25℃ - 31℃

  • weather-icon

    Sat

    26℃ - 30℃

Kalbe Farma inaugurates first biotech factory

  • News Desk
    News Desk

    The Jakarta Post

Jakarta | Thu, March 1, 2018 | 08:45 am
Kalbe Farma inaugurates first biotech factory President Joko "Jokowi” Widodo speaks at the inauguration of Kalbe Farma’s new biotechnology-based factory in Cikarang, West Java, on Tuesday. (JP/ktm)

PT Kalbe Farma has inaugurated its first biotechnology-based drug factory in what has been hailed as a milestone in the industry.

The publicly listed pharmaceutical company invested Rp 500 billion (US$35 million) to build the factory in Cikarang, West Java, and another Rp 200 billion for research and development, including technology transfer.

"The inauguration of this drug ingredient and biological product factory is part of Kalbe's commitment to take the initiative and help create an integrated pharmaceutical industry," Kalbe Farma president director Vidjongtius said in his speech at the factory's inauguration ceremony on Tuesday.

President Joko "Jokowi" Widodo and Health Minister Nila Moeloek, who also attended the event, said the factory marked significant progress for Indonesia's pharmaceutical industry.

"What Kalbe has constructed here is a great leap," Jokowi said after touring the factory. "Everything uses biotechnology and everything is automated with robotics. I think this is the kind of investment and technological innovation we need."

Nila echoed Jokowi's sentiment, saying the factory was a "transformation" and a "leap from chemical ingredients to biotechnological ones."

"This is an extraordinary technological achievement," she said.

The factory, which has a production capacity of 9 million units, has already started the production of erythropoietin (EPO), a protein that stimulates red blood cell production and is used in dialysis and other treatments. Kalbe Farma also plans to produce insulin, cancer-treating monoclonal antibodies and three other drugs within five years. (kmt/bbn).

Join the discussions